发明申请
- 专利标题： SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
- 专利标题（中）： 持续释放氨基吡啶组合物
-
申请号： US13585277申请日： 2012-08-14
-
公开(公告)号： US20130045276A1公开(公告)日： 2013-02-21
- 发明人: Sean Cunningham , Seamus Mulligan , Michael Myers
- 申请人： Sean Cunningham , Seamus Mulligan , Michael Myers
- 申请人地址： IE Athlone
- 专利权人： Alkermes Pharma Ireland Limited
- 当前专利权人： Alkermes Pharma Ireland Limited
- 当前专利权人地址： IE Athlone
- 主分类号： A61K9/22
- IPC分类号： A61K9/22 ; A61P25/00 ; A61P25/28 ; A61K31/4409
摘要：
A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.
信息查询
